INVIVO THERAPEUTICS HLDGS Press Releases

NVIV 
$1.39
*  
0.08
6.11 %
Get NVIV Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading NVIV now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
InVivo Therapeutics Announces FDA Approval to Expedite Enrollment for Ongoing Pilot Trial
12/16/2014 8:00:00 AM - Business Wire


InVivo Therapeutics Announces University of Pittsburgh Medical Center Presbyterian as New Clinical Trial Site for Neuro-Spinal Scaffold
11/25/2014 8:00:00 AM - Business Wire


InVivo Therapeutics Announces Oregon Health & Science University as Fifth Clinical Trial Site for Neuro-Spinal Scaffold
11/21/2014 8:00:00 AM - Business Wire


InVivo Therapeutics Announces Appointment of Ann Merrifield to Its Board of Directors
11/11/2014 8:00:00 AM - Business Wire


InVivo Therapeutics Reports 2014 Third Quarter Financial Results and Business Update
11/5/2014 4:30:00 PM - Business Wire


InVivo Therapeutics Receives FDA Approval to Broaden Inclusion Criteria and Add 14 Additional Sites (20 Total) for Ongoing Pilot Trial
10/29/2014 8:00:00 AM - Business Wire


InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc.
10/22/2014 7:30:00 AM - PR Newswire


InVivo Therapeutics Announces Barnes-Jewish Hospital at Washington University as New Clinical Trial Site for Neuro-Spinal Scaffold
10/20/2014 8:00:00 AM - Business Wire


InVivo Therapeutics Announces First Subject Enrolled in Pilot Spinal Cord Injury Trial
10/15/2014 8:00:00 AM - Business Wire


InVivo Therapeutics to Exhibit at 2014 Congress of Neurological Surgeons Annual Meeting
10/6/2014 8:00:00 AM - Business Wire


InVivo Therapeutics Announces Appointment of Daniel R. Marshak, PhD to Its Board of Directors
9/29/2014 8:00:00 AM - Business Wire